1530:HKEXAwea mechantronic co.,ltd Analysis
Data as of 2026-03-11 - not real-time
NT$27.05
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Awea mechantronic is trading well below its discounted cash‑flow estimate, suggesting a potential upside despite a trailing PE that sits far above the industry average. Revenue is contracting sharply and both gross and operating margins are in negative territory, highlighting current profitability challenges. The stock offers a high dividend yield of over five percent, but the payout ratio exceeds two hundred percent, raising questions about sustainability. Its price‑to‑book ratio is comfortably under one, indicating a discount to net asset value. The DCF fair value of roughly thirty‑seven TWD versus the current price near twenty‑seven TWD underscores the valuation gap. On the technical side, the price hovers just above the identified support of twenty‑six TWD and beneath a resistance near thirty TWD. The MACD has turned bearish while the RSI sits in the neutral‑low range, hinting at limited upside momentum in the short run. Volume is trending upward, which could signal accumulating interest. Volatility is elevated at nearly thirty percent over the past month, but beta remains modest, tempering market‑wide risk exposure. Geopolitical considerations tied to its Taiwanese operations add a medium‑level geographic risk. Overall, the company appears undervalued from a balance‑sheet perspective but faces near‑term earnings and cash‑flow headwinds.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram
- Price near recent support level
- High dividend yield but unsustainable payout
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF valuation indicates upside
- Price‑to‑book below one
- Potential earnings recovery as margins improve
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑run demand for specialty industrial machinery
- Undervalued balance‑sheet metrics
- Attractive dividend yield if payout ratio normalizes
Key Metrics & Analysis
Financial Health
Revenue Growth-26.30%
Profit Margin3.15%
P/E Ratio45.1
ROE1.79%
ROA-1.13%
Debt/Equity50.77
P/B Ratio0.8
Op. Cash FlowNT$303.9M
Free Cash FlowNT$285.3M
Industry P/E29.3
Technical Analysis
TrendNeutral
RSI38.7
SupportNT$26.00
ResistanceNT$30.00
MA 20NT$28.43
MA 50NT$28.26
MA 200NT$28.45
MACDBearish
VolumeIncreasing
Fear & Greed Index78.16
Valuation
Fair ValueNT$37.34
GradeUndervalued
TypeValue
Dividend Yield5.66%
Risk Assessment
Beta0.59
Volatility28.49%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.